Extended Abstract Submission Deadline
Submit your abstract before 15 April 2021
MAY - DEC
2021
2021
ISSAID
Periodic Congress
Programme
Programme
- Home
- Programme
Programme
Upcoming sessions
| June 2021 | |
|---|---|
 Add to calendar |
Wednesday 23 June 2021 – 17:00 – 19:00 |
| Session 3 | The clinical presentation and treatment of MIS-C around the world |
| Moderators: Jasmine Kuemmerle-Deschner (DE), Joost Frenkel (NL) |
|
| 17:00 | The kaleidoscope of MIS-C Angelo Ravelli (IT) |
| 17:20 | O03 - Long-term cardiac outcome in patients with multisystem inflammatory syndrome in children (MIS-C) Fiammetta Zunica (IT) |
| 17:30 | Panel Discussion MIS-C: News from the World Isabelle Koné-Paut (FR): MIS-C in Europe Maria Cecilia Poli Harlowe (CL): MIS-C in South America Kate Webb (ZA): MIS-C in Africa Suma Balan (IN): MIS-C in India Fatma Dedeoglu (US): MIS-C in North America |
| July 2021 | |
|---|---|
Add to calendar |
Wednesday 7 July 2021 – 17:00 – 19:00 |
| Session 4 | Pulmonary involvement in autoinflammatory diseases (SAIDs) |
| Moderators: Seza Ozen (TR), Paul Brogan (UK) |
|
| 17:00 | Interferonopathies Raphaela Goldbach-Mansky (US) |
| 17:20 | Systemic Onset Juvenile Idiopathic Artiritis Bas Vastert (NL) |
| 17:40 | Discussion |
| NOVARTIS Symposium | Novel Approaches to Personalized Patient Care in Still’s Disease |
| 18:00 |
Welcome and Introduction |
| 18:05 |
Biomarkers and Their Sense or Nonsense in the Management of Still’s Disease |
| 18:20 | Digital Tools for the Management of Rare Autoinflammatory Diseases Johannes Knitza, MD, MHBA (DE) |
| 18:35 | The Transition from Paediatric to Adult Care: What Can We Learn From Experience with JIA? Carine Wouters, MD, PhD (BE) |
| 18:50 | “Ask the Faculty” and Take-Home Messages Carine Wouters, MD, PhD (BE), Lorenzo Dagna, MD (IT) and Johannes Knitza, MD, MHBA (DE) |
Add to calendar |
Wednesday 21 July 2021 – 17:00 – 19:00 |
| Session 5 | Autoinflammation in COVID-19 |
| Moderators: Isabelle Koné-Paut (FR), Marco Gattorno (IT) |
|
| 17:00 | Inflammatory cell death (pyroptosis) in SARS-CoV-2 infection Judy Lieberman (US) |
| 17:20 | Genetic and immune determinants of response to SARS-CoV-2 Luigi Notarangelo (US) |
| 17:40 | The pathogenesis and clinical spectrum of MIS-C Lauren Henderson (US) |
| 18:00 | O04 - SARS-COV2 ORF3A protein drives inflammation in COVID-19 through NLRP3 inflammasome activation Stefano Volpi (IT) |
| 18:10 | Discussion |
| NOVARTIS Meet the Expert | Meet the experts: Stills’ disease and its mimics |
| 18:30 | New data on biomarkers in AOSD - does it help for diagnosis and prognosis? Eugen Feist, Germany |
| 18:40 | Still’s disease – overlays to monogenetic diseases? Sinisa Savic, United Kingdom |
| 18:50 | Q&A All |
| September 2021 | |
|---|---|
Add to calendar |
Wednesday 8 September 2021 – 17:00 – 19:00 |
| Session 6 | Hematological aspects of autoinflammation |
| Moderators: Quing Zhou (CN) |
|
| 17:00 | Clinical lecture: myelodysplastic syndrome, Schinzel, VEXAS Sinisa Savic (UK) |
| 17:20 | Clinical aspects of Ripk1 autoinflammatory disease (CRIA syndrome) Deborah Stone (US) |
| 17:40 | Pathogenic basis of Ripk1 autoinflammatory disease Najoua Lalaoui (AU) |
| 18:00 | O05 - Defining clinical and genetic hallmarks of VEXAS syndrome Daniela Ospina Cardona (US) |
| 18:10 | O06 - Adult-onset autoinflammation caused by somatic mutations in UBA1: a Dutch case series of VEXAS patients Caspar Ivan van der Made (NL) |
| 18:20 | Discussion |
Add to calendar |
Wednesday 22 September 2021 – 17:00 – 19:00 |
| Session 7 | Metabolism and Autoinflammation |
| Moderators: Scott Canna (US) |
|
| 17:00 | The clinical spectrum of LACC1-disorders Sulaiman Al-Mayouf (SA) |
| 17:20 | Famin/LACC1 Alexandre Belot (FR) |
| 17:40 | IL-1 blockade in heart disease Antonio Abbate (US) |
| 18:00 | O07 - Short-term follow-up results of children with Familial Mediterranean Fever after cessation of Canakinumab Hafize Emine Sönmez (TR) |
| 18:10 |
O08 - Traditional laboratory parameters and new biomarkers in Macrophage Activation Syndrome (MAS) and Secondary Hemophagocytic Lymphohistiocytosis (SHLH) |
| 18:20 | Discussion |
| October 2021 | |
|---|---|
Add to calendar |
Wednesday 6 October 2021 – 17:00 – 19:00 |
| Session 8 | Enzymes bridging the gap between genes, autoimmunity and inflammation |
| Moderators: Marie-Louise Frémond (FR), Stefano Volpi (IT) |
|
| 17:00 | A clinical overview on TREX1 and DNASE2 Yannick Crow (UK) |
| 17:20 | Bridging monogenic diseases with autoimmunity Boris Reizis (US) |
| 17:40 | Linking plasma DNA profiles with nucleases Dennis Lo (HK) |
| 18:00 | O09 - Dissecting netosis in adenosine deaminase 2 deficiency (DADA2) patients Francesca Schena (IT) |
| 18:10 | Oral communication 2 |
| 18:20 | Discussion |
Add to calendar |
Wednesday 20 October 2021 – 17:00 – 19:00 |
| Session 9 | Approaches to genomic mutation detection in SAID |
| Moderator: Isabelle Touitou (FR) |
|
| 17:00 | Genotype-driven, phenotype-neutral approach; detection of VEXAS syndrome David Beck (US) |
| 17:20 | Phenotype-driven genomic diagnostics; LIRICAL Peter Robinson (US) |
| 17:40 | Human phenotype ontology and its importance in autoinflammation Marielle van Gijn (NL) |
| 18:00 | O10 - Next generation sequencing based multiplex long-range PCR for routine genotyping of autoinflammatory disorders Erkan Demirkaya (CA) |
| 18:10 | Oral communication 2 |
| 18:20 | Discussion |
| November 2021 | |
|---|---|
Add to calendar |
Wednesday 3 November 2021 – 17:00 – 19:00 |
| Session 10 | New therapies in autoinflammation |
| Moderator: Scott Canna (US) |
|
| 17:00 | General lecture: an update on treatment Helen Lachmann (UK) |
| 17:20 | New approaches to inhibition of autoinflammation for inflammasomes inhibition Luke O'Neill (IE) |
| 17:40 | Blocking the IFN pathway Andrea Ablasser (CH) |
| 18:00 | O11 - Gene therapy for IL-1-mediated systemic autoinflammatory diseases Mariasilvia Colantuoni (IT) |
| 18:10 | O12 - Application of systems biology-based in silico tools to optimize treatment strategy in Still’s disease Mireia Coma (ES) |
| 18:20 | Discussion |
Add to calendar |
Wednesday 17 November 2021 – 17:00 – 19:00 |
| Session 11 | New guidelines for autoinflammatory diseases |
| Moderators: Raphaela Goldbach-Mansky (US), Erkan Demirkaya (CA) |
|
| 17:00 | Interferonopathies |
| 17:30 | IL-1 mediated diseases |
| 18:00 | HLH-MAS |
| 18:30 | Discussion |
| December 2021 | |
Add to calendar |
Wednesday 1 December 2021 – 17:00 – 19:00 |
| Session 12 | New genetic causes of SAID in 2021 |
| Moderators: Marco Gattorno (IT), Helen Lachmann (UK) |
|
| 17:00 | Overview of genetic cause of SAID - 2021 update Ivona Aksentijevich (US) |
| 17:20 | Oral communication 1 |
| 17:30 | Oral communication 2 |
| 17:40 | Oral communication 3 |
| 17:50 | Oral communication 4 |
| 18:00 | Oral communication 5 |
| 18:10 | Oral communication 6 |
| 18:20 | Discussion |
Past sessions available on-demand
| May 2021 | |
|---|---|
| Register & Watch recording |
Wednesday 26 May 2021 – 17:00 – 19:00 |
| Moderators: Marco Gattorno (IT), Helen Lachmann (UK) | |
| Opening session: | Opening Lecture |
| 17:00 | The expansion of the autoinflammatory universe Dan Kastner (US) |
| Session 1 | (auto)inflammatory consequences of actin dysregulation |
| 17:20 | Clinical features of (auto)inflammatory consequences of actin dysregulation Paul Brogan (UK) |
| 17:40 | Mechanistic insights: autoinflammation and actin Kaan Boztug (AT) |
| 18:00 | O01 - The possible effect of MIR-30E-3P which targets IL-1β in the pathogenesis of systemic autoinflammatory diseases Tayfun Hi̇lmi̇ Akbaba (TR) |
| 18:10 | O02 - Number of episodes can be used as a disease activity measure in Familial Mediterranean Fever David Piskin (CA) |
| 18:20 | Discussion |
| June 2021 | |
|---|---|
| Register & Watch recording |
Wednesday 9 June 2021 – 17:00 – 19:00 |
| Session 2 | Diagnosis and management of non-genetically determined recurrent fevers |
| Moderators: Amita Arggawal (IN), Philip Hashkes (IL) |
|
| 17:00 |
State-of-the art lecture: Everything you need to know about PFAPA in 2021 |
| 17:20 | Round table discussion: How do I manage patients with recurrent fevers of unknown origin (PFAPA, SURF, etc) Michael Hofer (CH): How do I make diagnosis? Lori Broderick (US): Is SURF a clinical entity? Sophie Georgin-Lavialle (FR): Undefined recurrent fevers in adults Saskya Angevare (NL) and Karen Durrant (US): Patients perspectives |
| View full programme | Familial Mediterranean Fever: Contextualizing anti IL-1 Therapy to Achieve and Sustain Therapy Goals |
| 18:00 |
Welcome and opening remarks |
| FMF treatment goals Meeting and sustaining patient need Eldad Ben-Chetrit (IL) |
|
| What are the treatment expectations for a patient with FMF Considering a holistic approach to achieve quality of life goals? Veronique Hentgen (FR) |
|
| Anti IL-1 therapy treatment paradigms Marco Gattorno (IL) |
|
| Live panel discussion: Summing it up | |
About us
The International Society of Systemic Auto-Inflammatory Diseases (ISSAID) raise awareness, catalyse basic research and promote scientific and clinical knowledge on all aspects of systemic auto-inflammatory diseases.
Contact Information
ISSAID 2021 c/o MCI Geneva
9, rue du Pré-Bouvier
1242, Satigny, Geneva
Switzerland
Phone:
+41 22 33 99 673
E-mail: issaid@mci-group.com
Registration: issaid.reghot@mci-group.com
Abstracts: issaid.abs@mci-group.com
Official Website:
www.issaid.org